Dr. Hamid Discusses Melanoma Treatment

Omid Hamid, MD
Published: Monday, Oct 28, 2013

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses the treatment of melanoma.

Hamid urges community physicians to seek a second opinion when they are unsure about a certain tumor type. After obtaining a second opinion, the patient can then go back to the community oncologist with a therapeutic plan and some expertise behind the decision. In the community, Hamid urges physicians to read up on immunotherapy and its benefits.

However, a physician should not follow a recommendation without considering his or her clinical experience, Hamid says. The physician should also factor in the patient’s desires and have a discussion about toxicities.

Hopefully, the first-line therapy will lead to long-term benefit, Hamid says. If not, either targeted or immunotherapy treatment is available.

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses the treatment of melanoma.

Hamid urges community physicians to seek a second opinion when they are unsure about a certain tumor type. After obtaining a second opinion, the patient can then go back to the community oncologist with a therapeutic plan and some expertise behind the decision. In the community, Hamid urges physicians to read up on immunotherapy and its benefits.

However, a physician should not follow a recommendation without considering his or her clinical experience, Hamid says. The physician should also factor in the patient’s desires and have a discussion about toxicities.

Hopefully, the first-line therapy will lead to long-term benefit, Hamid says. If not, either targeted or immunotherapy treatment is available.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication
x